Gräf M, Kalinowski H O
Augenklinik für Schielbehandlung und Neuroophthalmologie.
Klin Monbl Augenheilkd. 1995 Apr;206(4):262-5. doi: 10.1055/s-2008-1035436.
The efficiency of cysteamine eye drops in the treatment of cystinosis has been demonstrated in several studies: Corneal cystine crystals can be removed by topical cysteamine. Cysteamie 0.5% eye drops were superior to a 0.1% solution. It is not clear how fast cysteamine is oxidized to cystamine under the influence of atmospheric oxygen.
Samples of a new bottled cysteamine 0.5% solution were analysed 1H-NMR-spectroscopically over a period of several weeks (AM 400/WB-NMR-instrument, Bruker/Karlsruhe; 400.15 MHz). Samples bottled in an argon atmosphere were compared to samples bottled without inert gas. Definite samples were opened four times a day (A). The remainder of the samples was stored closed (B).
In sample A a 1:1 weight ratio between cysteamine and cystamine was reached after 38 days. In samples B cysteamine was not oxidized to cystamine. The initial amount of cystamine was something lower in samples with argon, but argon could not prevent the decrease of the cysteamine concentration in sample A.
The preparation of cysteamine solution in an argon atmosphere is useful. One bottle can be used for about one week, if less than 10% of the oxidation product cystamine is accepted.
多项研究已证实半胱胺滴眼液治疗胱氨酸病的有效性:局部应用半胱胺可清除角膜胱氨酸结晶。0.5%的半胱胺滴眼液优于0.1%的溶液。目前尚不清楚在大气氧的影响下,半胱胺氧化为胱胺的速度有多快。
采用1H-核磁共振光谱法,在数周时间内对新瓶装的0.5%半胱胺溶液样本进行分析(AM 400/WB-核磁共振仪,布鲁克公司/卡尔斯鲁厄;400.15兆赫)。将装在氩气氛围中的样本与未充惰性气体的样本进行比较。确定的样本每天打开四次(A组)。其余样本密封保存(B组)。
在A组样本中,38天后半胱胺与胱胺的重量比达到1:1。在B组样本中,半胱胺未氧化为胱胺。充氩样本中胱胺的初始量略低,但氩气无法阻止A组样本中半胱胺浓度的降低。
在氩气氛围中制备半胱胺溶液是有用的。如果接受的氧化产物胱胺少于10%,一瓶溶液大约可以使用一周。